SCHEMBL7330979

SCHEMBL7330979

Cc1ccc(C[C@H](NC(=O)[C@@H](NC(=O)OCc2ccccn2)C(C)C)[C@H](O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)OCc2ccccn2)C(C)C)cc1

nearest known ligand 0.61

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.61
CTSD P07339 5/20 0.56
PGR P06401 1/20 0.45
ADORA3 P0DMS8 1/20 0.45
PTGS1 P23219 1/20 0.45
SLC6A2 P23975 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2D6 P10635 1/20 0.45
MAPT P10636 1/20 0.45
TSHR P16473 1/20 0.45
CASP3 P42574 1/20 0.45
CASP7 P55210 1/20 0.45
REN P00797 1/20 0.45
NPC1 O15118 1/20 0.43
LMNA P02545 1/20 0.43
RAB9A P51151 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7275899 0.95 CA2 (0.66) CA2CTSDPGRADORA3PTGS1
SCHEMBL7270130 0.93 CA2 (0.64) CA2CTSDSMN1; SMN2CYP1A2CYP2D6
SCHEMBL7343161 0.93 CA2 (0.69) CA2CTSDPGRADORA3PTGS1
SCHEMBL6445023 0.93 CA2 (0.69) CA2CTSDPGRADORA3PTGS1
SCHEMBL6447680 0.93 CA2 (0.69) CA2CTSDPGRADORA3PTGS1
SCHEMBL6449063 0.93 CA2 (0.69) CA2CTSDPGRADORA3PTGS1
SCHEMBL9227910 0.93 CA2 (0.69) CA2CTSDPGRADORA3PTGS1
SCHEMBL7330634 0.93 CA2 (0.59) CA2CTSDSMN1; SMN2CYP1A2CYP2D6
SCHEMBL7333160 0.93 CA2 (0.59) CA2CTSDSMN1; SMN2CYP1A2CYP2D6
SCHEMBL7331875 0.92 CA2 (0.58) CA2CTSDSMN1; SMN2CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0997459-A1 Intermediates for preparing retroviral protease inhibiting compounds Abbott Laboratories (US) 2000-05-03 EP disclosed
US-5837873-A PROTECTED OXYDIAMINES ABBOTT LABORATORIES (US) 1998-11-17 US disclosed
US-5648497-A Retroviral protease inhibiting compounds ABBOTT LABORAOTRIES (US) 1997-07-15 US disclosed
US-5616714-A PYRIDYL, THIAZOLYL-SUBSTITUTED AMINO ACID DERIVATIVES ABBOTT LABORATORIES (US) 1997-04-01 US disclosed
US-5597926-A Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1997-01-28 US disclosed
US-5541334-A TREATING HIV ABBOTT LABORATORIES (US) 1996-07-30 US disclosed
US-5354866-A Treating HIV infections ABBOTT LABORATORIES (US) 1994-10-11 US disclosed
EP-0486948-A2 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1992-05-27 EP disclosed